Fett Nicole M, Fiorentino David, Werth Victoria P
Department of Dermatology, Center for Health and Healing, Oregon Health & Science University, 3303 Southwest Bond Avenue, 16th Floor, Portland, OR 97239, USA.
Department of Dermatology, Stanford University School of Medicine, 450 Broadway, Redwood City, CA 94063, USA.
Dermatol Clin. 2016 Jul;34(3):243-50. doi: 10.1016/j.det.2016.02.006.
Patients with skin-predominant lupus erythematosus, dermatomyositis, and morphea should be evaluated, treated, and followed by dermatologists who can take primary responsibility for their care. Many academic centers have specialized centers with dermatologists who care for these patients. Patients with skin-predominant lupus erythematosus should be followed regularly with laboratory tests to detect significant systemic disease. Antibody tests can help determine the risks for individual patients. Patients with morphea rarely progress to systemic disease, but therapies can be helpful in treating and preventing progression of disease.
以皮肤表现为主的红斑狼疮、皮肌炎和硬斑病患者应由能够对其护理承担主要责任的皮肤科医生进行评估、治疗和随访。许多学术中心设有由皮肤科医生负责护理这些患者的专科中心。以皮肤表现为主的红斑狼疮患者应定期进行实验室检查以发现明显的系统性疾病。抗体检测有助于确定个体患者的风险。硬斑病患者很少发展为系统性疾病,但治疗有助于治疗和预防疾病进展。